All Stories

  1. Three-Dimensional Bioprinting and Rose-Inspired Medical Applications
  2. Forecasting Upper Bounds for Daily New COVID-19 Infections Using Tolerance Limits
  3. Distribution of microRNA Counts Across Human Chromosomes
  4. Medical Benefits and Polymer Applications of Grapes
  5. EWMA Control Chart Integrated with Time Series Models for COVID-19 Surveillance
  6. A Review of Nanotechnology in microRNA Detection and Drug Delivery
  7. Advantages of animal leather over alternatives and its medical applications
  8. Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA
  9. Beneficial medicinal effects and material applications of rose
  10. The Potential of Collagen Treatment for Comorbid Diseases
  11. Tolerance limits for mixture‐of‐normal distributions with application to COVID‐19 data
  12. Biomaterials in Medical Applications
  13. The Human Pre-miRNA Distance Distribution for Exploring Disease Association
  14. microRNA pathological mechanisms between Parkinson's disease, Alzheimer's disease, glaucoma and macular degeneration
  15. The distance distribution of human microRNAs in MirGeneDB database
  16. Phylogenetic Tree Selection by Testing Substitution Number in Clade
  17. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data
  18. A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson’s Disease
  19. COVID−19, Anti-NMDA Receptor Encephalitis and MicroRNA
  20. microRNA Biomarkers in Clinical Study
  21. Multiple imputation confidence intervals for the mean of the discrete distributions for incomplete data
  22. A Review of the Effects of Collagen Treatment in Clinical Studies
  23. The Association between Migraine and Depression based on miRNA Biomarkers and Cohort Studies
  24. MicroRNAs, Multiple Sclerosis, and Depression
  25. Editorial: miRNAs and Neurological Diseases
  26. MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
  27. Confidence intervals for the proportion of conformance
  28. Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut Microbiome
  29. Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis
  30. The Generalized Bayes Method for High-Dimensional Data Recognition with Applications to Audio Signal Recognition
  31. MicroRNA, Diabetes Mellitus and Colorectal Cancer
  32. The Association between Depression and Gastroesophageal Reflux based on Phylogenetic Analysis of miRNA Biomarkers
  33. <p>Exploring Diversity of COVID‑19 Based on Substitution Distance</p>
  34. Monitoring Change Points by a Sign Change Method
  35. MicroRNAs and Apoptosis in Colorectal Cancer
  36. Constructing exact tolerance intervals for the exponential distribution based on record values
  37. Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker
  38. Logistic Regression Method for Ligand Discovery
  39. Exact two‐sided tolerance interval controlling tail proportions for sample variances
  40. Anti-NMDA Receptor Encephalitis, Vaccination and Virus
  41. Vaccines and Neurological Disease
  42. Phylogenetic Analysis to Explore the Association Between Anti-NMDA Receptor Encephalitis and Tumors Based on microRNA Biomarkers
  43. Tolerance interval for the mixture normal distribution
  44. Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
  45. How can we identify Amyotrophic Lateral Sclerosis with blood test?
  46. A protocol for investigating the association of vaccination and anti-NMDA receptor encephalitis
  47. Constructing Tolerance Intervals for the Number of Defectives Using Both High- and Low-Resolution Data
  48. Why ALS is often associated with cancers?
  49. A control chart for the lognormal standard deviation
  50. Anti-NMDA Receptor Encephalitis and Vaccination
  51. Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis
  52. On the monitoring of mixture simple linear profiles
  53. Efficacies of treatments for anti-NMDA receptor encephalitis
  54. Corrigendum to “Variance estimation for nucleotide substitution models” [Mol. Phylogenet. Evol. 90 (2015) 97–103]
  55. Multivariate control charts based on the James–Stein estimator
  56. Variance estimation for nucleotide substitution models
  57. Control Charts for the Lognormal Mean
  58. Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue
  59. Correction: Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  60. Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  61. Shrinkage regression-based methods for microarray missing value imputation
  62. RRSM with a data-dependent threshold for miRNA target prediction
  63. Bayesian Ranking Responses in Multiple-Response Questions
  64. Protein-specific Scoring Method for Ligand Discovery
  65. Confidence intervals for a bounded mean in exponential families
  66. Phylogenetic tree selection by the adjustedk-means approach
  67. Human microRNA target identification by RRSM
  68. Yeast cell cycle transcription factors identification by variable selection criteria
  69. Confidence intervals for the substitution number in the nucleotide substitution models
  70. Constructing Biological Pathways by a Two-Step Counting Approach
  71. Approximate Tolerance Limits Under Log-Location-Scale Regression Models in the Presence of Censoring
  72. Closed Form Prediction Intervals Applied for Disease Counts
  73. The monotone boundary property and the full coverage property of confidence intervals for a binomial proportion
  74. Comparison of control charts for low defective rate
  75. Increasing MicroRNA target prediction confidence by the relative R2 method
  76. Tolerance Intervals With Improved Coverage Probabilities for Binomial and Poisson Variables
  77. Improved variance estimators for one- and two-parameter models of nucleotide substitution
  78. Confidence intervals for the mean of a normal distribution with restricted parameter space
  79. Coverage probability of prediction intervals for discrete random variables
  80. Exact average coverage probabilities and confidence coefficients of confidence intervals for discrete distributions
  81. Exact confidence coefficients of simultaneous confidence intervals for multinomial proportions
  82. Ranking responses in multiple-choice questions
  83. ϵ-Admissible Estimators for Normal and Poisson Means
  84. Estimation of the Probability of Passing the USP Dissolution Test
  85. Modified p-values for one-sided testing in restricted parameter spaces
  86. Modified p-Value of Two-Sided Test for Normal Distribution with Restricted Parameter Space
  87. Improved confidence estimators for confidence sets of location parameters
  88. Improved estimation of accuracy in simple hypothesis versus simple alternative testing
  89. Improved confidence estimators for the usual one-sided confidence intervals for the ratio of two normal variances
  90. Admissibility of Confidence Estimators in the Regression Model
  91. The problem of low counts in a signal plus noise model
  92. Brown's paradox in the estimated confidence approach
  93. Estimated confidence under ancillary statistic everywhere-valid constraint
  94. Admissibility of the constant-coverage probability estimator for estimating the coverage function of certain confidence interval